Literature DB >> 2179591

Rotation of the anatomic regions used for insulin injections and day-to-day variability of plasma glucose in type I diabetic subjects.

J P Bantle1, M S Weber, S M Rao, M K Chattopadhyay, R P Robertson.   

Abstract

Treatment of type I diabetes mellitus is hindered by the often large fluctuations in blood glucose concentration experienced by affected individuals. To determine to what extent day-to-day variation in blood glucose levels can be reduced if insulin is injected in the same anatomic region rather than in different regions using a rotational scheme, as is commonly recommended, 12 type I diabetic subjects were studied. Insulin injections were given in the abdomen for 3 days and rotated among arms, abdomen, and thighs for 3 days using a crossover design with random assignment of treatment order. Blood samples for measurement of plasma glucose levels were obtained at nine scheduled times on each day. Insulin dose, diet, and physical activity were held constant for each subject. During the abdominal injection period, the mean SD of plasma glucose levels and the mean variance of plasma glucose levels were both less at all nine time points than during the rotating injection period. Overall values for the SD of plasma glucose levels were 2.7 +/- 0.2 mmol/L for the abdominal injection period and 3.7 +/- 0.3 mmol/L for the rotating injection period. Overall values for the variance of plasma glucose levels were 9.2 +/- 1.4 mmol2/L2 for the abdominal injection period and 17.4 +/- 2.2 mmol2/L2 for the rotating injection period. We conclude that the common clinical practice of rotating the anatomic regions used for insulin injections increases day-to-day variation in blood glucose concentration. Use of a single anatomic region, eg, the abdomen, for all insulin injections may reduce this variation and allow greater precision in the adjustment of insulin doses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179591

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

Review 1.  Insulin-dependent (type I) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

2.  Subcutaneous or intramuscular insulin injections.

Authors:  C P Smith; M A Sargent; B P Wilson; D A Price
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

Review 3.  Glycaemia control in diabetes mellitus. Towards the normal profile?

Authors:  B R Zimmerman
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

4.  Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional.

Authors:  Sanjay Kalra; Ambrish Mithal; Rakesh Sahay; Mathew John; A G Unnikrishnan; Banshi Saboo; Sujoy Ghosh; Debmalya Sanyal; Laurence J Hirsch; Vandita Gupta; Kenneth W Strauss
Journal:  Diabetes Ther       Date:  2017-03-13       Impact factor: 2.945

Review 5.  Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability.

Authors:  A K J Gradel; T Porsgaard; J Lykkesfeldt; T Seested; S Gram-Nielsen; N R Kristensen; H H F Refsgaard
Journal:  J Diabetes Res       Date:  2018-07-04       Impact factor: 4.011

6.  Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire.

Authors:  Selcuk Dagdelen; Oguzhan Deyneli; Nermin Olgun; Zeynep Osar Siva; Mehmet Sargin; Sükrü Hatun; Mustafa Kulaksizoglu; Ahmet Kaya; Cansu Aslan Gürlek; Laurence J Hirsch; Kenneth W Strauss
Journal:  Diabetes Ther       Date:  2018-06-30       Impact factor: 2.945

7.  Comparison between a flash glucose monitoring system and a portable blood glucose meter for monitoring dogs with diabetes mellitus.

Authors:  Francesca Del Baldo; Claudia Canton; Silvia Testa; Harry Swales; Ignazio Drudi; Stefania Golinelli; Federico Fracassi
Journal:  J Vet Intern Med       Date:  2020-10-30       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.